24 results about "Nicotine delivery" patented technology

The invention discloses a buccal nicotine bag product and a preparation method thereof. The buccal nicotine bag product comprises a content and an outer package, the content is powdery and comprises a nicotine source and an acidic pH regulator; the outer package is a saliva permeable pouch and is used for packaging the content, so that the pH value of the buccal nicotine pouch product in pure water or saliva is smaller than 6.0. Optimizing the pH value to a weakly acidic range (pH lt; a specific buffer system and a slow-release carrier are combined to solve the problems of oral cavity stimulation, flavor limitation and high pH dependence in the using process of an existing nicotine bag, the palatability of the nicotine bag in the using process and the nicotine release efficiency in the mouth consumption process are improved, long-acting and stable nicotine delivery is achieved by controlling release kinetics, the production cost is reduced, and the nicotine bag is suitable for large-scale popularization and application. The consumption experience is improved.

A security tag can prohibit unauthorized usage of a device or product. The device may include an electronic nicotine delivery systems (“ENDS”) device, which may include aerosol delivery devices such as smoking articles that produce aerosol. The security tag can prevent usage until authorized. Attempts at usage without authorization can result in the device being unusable. The authorization may include identity confirmation or age verification.

A nicotine delivery device (200) for generating a mist containing nicotine for inhalation by a user. The device comprises a mist generator device (201) and a driver device (202). The driver device (202) is configured to drive the mist generator device (201) at an optimum frequency to maximise the efficiency of mist generation by the mist generator device (201).

1. A filter material for producing a nicotine delivery product, comprising: a filter material comprising: a first filter layer; a second filter layer; and a third filter layer having a thickness of at least 25 g / m. The filter material comprises at least 50% by weight and at most 100% by weight of cellulose fibers, based on the weight of the filter material. 2 And a maximum of 60g / m 2 and the filter material has a structure characterized in that it provides the filter material with a transparency of at least 45% and at most 70% as measured according to DIN 53147:1993-01.Further described are segments comprising the filter material for nicotine delivery products, smoking devices comprising such segments, oral nicotine delivery products, and methods of making the filter material.

Nicotine-containing formulations for electric / electronic nicotine delivery systems are disclosed, containing both nicotine at relatively much higher concentrations, typically at least 25% by weight of total formulation weight, w / w, and in many cases as much as 40-50% w / w, than is typical for conventional nicotine containing formulations, which only contain about 2-4% w / w nicotine. The formulations also include a biologically and pharmaceutically acceptable mono- or di-carboxylic organic acid, such as benzoic acid, salicylic acid and most preferably lactic acid also at relatively high w / w concentrations. One or more nicotine salts may be created and be extant within the formulations, which not only mitigates against the loss of nicotine to the atmosphere through natural volatility and evaporation, but also markedly increases the surface energy of the formulations created, and the globules of formulations deposited on a heating substrate are much more cohesive and much less likely to migrate through wetting over the substrate.

An electronic nicotine delivery systems (“ENDS”) device may include aerosol delivery devices such as smoking articles that produce aerosol. The device may include a cartridge for the aerosol production. The cartridge is assigned a unique identifier that is approved for a user or that user's device such that the cartridge and / or the device only operate when approved. The unique identifiers help with user identification, tracking, and age verification.

Nicotine delivery devices and systems, particularly smoking cessation systems are provided by the present disclosure. Such devices and systems produce a nicotine-containing aerosol for inhalation that mimics smoking. The devices are capable of being adapted to control the amount of nicotine delivered to taper the amount of nicotine delivered to the user over time. Methods for treating patients to stop smoking are also disclosed. The devices, systems and methods can also be used to deliver other drugs disclosed herein, such as opioids (e.g., fentanyl).

The present invention relates to a smokeless article for oral consumption comprising a pouch enclosing an oral nicotine delivery (OND) formulation, the OND formulation comprising a water insoluble bulking agent and an active component comprising a complex of a sugar alcohol and nicotine. Methods of manufacturing the article and kits comprising the article are also described.

This invention discloses a nicotine delivery control method, system, electronic device, and storage medium. The method includes: acquiring baseline physiological signal data of a user in a resting state via a biosignal acquisition module; establishing an individual physiological baseline value for the user based on the baseline physiological signal data via an edge computing processing module; acquiring the user's current physiological signal data in real time via the biosignal acquisition module during user use; determining the user's current emotional state based on the current physiological signal data and the individual physiological baseline value via the edge computing processing module, and generating a heating strategy instruction corresponding to the current emotional state; and receiving and executing the heating strategy instruction via a dynamic heating execution module to adjust the heating method of the cigarette, thereby achieving nicotine delivery control. The technical solution of this invention achieves personalized nicotine delivery by identifying the user's emotional state during use and dynamically adjusting the nicotine delivery rate accordingly.

The invention relates to the technical field of electronic atomization control, and discloses an atomization device and an atomization device adjusting system and method. The adjusting method of the atomization device comprises the following steps that the nicotine delivery amount and flavor sensing information are obtained; making an adjustment strategy according to the nicotine delivery amount compared with a target value and the flavor perception information; and executing the regulation strategy, including regulating the throat striking feeling or the nicotine delivery amount. According to the adjusting method, the overall satisfaction and experience consistency of the user can be maintained, the user experience is improved, and the viscosity of the user is improved.

The Invention relates to an oral nicotine delivery product containing a composition enclosed in a water-insoluble pouch, said pouch being permeable to saliva and to dissolved compounds of the composition, the composition comprising a nicotine source and cellulose or a cellulose derivative, the cellulose or cellulose derivative being in granular form. The invention further relates to a method for preparing the product for oral administration of nicotine.

The invention discloses a nicotine release system and a preparation method thereof, the nicotine release system comprises a nicotine controlled-release component, a penetration enhancer and a nicotine slow-release salt, the nicotine slow-release salt is an ultramicro nano composite nicotine slow-release salt, the nicotine slow-release salt comprises at least one of citrate, malate and lactate, and the penetration enhancer is an ultramicro nano composite nicotine slow-release salt. The particle size of the nicotine sustained-release salt is 200-500nm, and the specific surface area of the nicotine sustained-release salt is 150 + / -50m < 2 > / g. According to the nicotine slow-release salt, the dissolving effect of nicotine in the oral cavity is relatively good.

1. The name of the design product: electronic cigarette (KK001 twin city). 2. The use of the design product: electronic cigarette refers to electronic nicotine delivery system. 3. The design points of the design product: in shape. 4. The picture or photo that best indicates the design points: perspective drawing.

The present invention relates to a smokeless article for oral consumption comprising a pouch enclosing an oral nicotine delivery (OND) formulation, the OND formulation comprising a water insoluble bulking agent and an active component comprising a complex of a sugar alcohol and nicotine. Methods of manufacturing the article and kits comprising the article are also described.

The invention discloses a nicotine dental strip and a preparation method thereof. The nicotine dental strip has a three-dimensional shape matched with the shape of teeth. The nicotine tooth paste comprises a release film layer, a gel layer and a protective layer which are stacked in the thickness direction, the gel layer includes a nicotine source. According to the utility model, the nicotine tooth paste is directly and fixedly adhered to the surface of the tooth, especially the back side of the tooth, so that the problems that the nicotine buccal product cannot be fixed in the oral cavity and is easy to displace, wrinkle or fall off are solved, and the foreign body sensation and mistaken swallowing risk of the nicotine product in the oral cavity are reduced; on the premise of not influencing normal diet and social contact, the nicotine delivery position is constant, the nicotine release is more stable, the flavor in the oral cavity is full and consistent, the irritation of the nicotine tooth paste to the oral cavity and the stomach is remarkably reduced, the comfort and the user acceptance are greatly improved, and consumers have better consumption experience.

A security tag can prohibit unauthorized usage of a device or product. The device may include an electronic nicotine delivery systems (“ENDS”) device, which may include aerosol delivery devices such as smoking articles that produce aerosol. The security tag can prevent usage until authorized. Attempts at usage without authorization can result in the device being unusable. The authorization may include identity confirmation or age verification.

The present application describes a filter material for manufacturing a nicotine delivery product, the filter material being hydroentangled and comprising at least 50% and at most 100% of cellulose fibers relative to the mass of the filter material, wherein the filter material has a basis weight of at least 25 g / m 2 and at most 60 g / m 2 and wherein the filter material has a structure characterized in that it ensures that the filter material has a transparency of at least 45% and at most 70% measured according to DIN 53147:1993-01. Furthermore, the present application also describes a portion of a nicotine delivery product, the portion comprising a filter material; a smoking article comprising such a portion; an oral nicotine delivery product; and a method of manufacturing a filter material.

The invention discloses a dual-purpose nicotine delivery film and a preparation method and application thereof, and the dual-purpose nicotine delivery film comprises the following components in parts by weight: 10-25 parts of a film forming substrate, 3-8 parts of an adhesive, 3-8 parts of nicotine, 25-60 parts of a smoke agent or a humectant, 0.5-4 parts of a flavoring agent, 5-30 parts of a humidity regulator and 0.5-3 parts of an acid-base regulator. According to the dual-purpose nicotine delivery film, the effective components such as the tobacco extract, the nicotine salt, the polyhydric alcohol, the natural or synthetic flavor substance, the water and the weakly alkaline food additive are uniformly dispersed in the adhesion layer, so that the dual-purpose nicotine delivery film which not only can be used for heating non-combustible tobacco products but also can be used for oral transdermal delivery of nicotine products is obtained; the use ways of the obtained film are enriched, and the utilization rate of nicotine products is increased.

The present invention relates to a smokeless article for oral delivery comprising a pouch enclosing an oral nicotine delivery (OND) formulation, the OND formulation comprising at least two pH regulators selected from the list of sodium carbonate, sodium hydroxide, calcium lactate, sodium phosphate dibasic, sodium citrate, meglumine, ammonia, ammonium carbonate, and calcium carbonate. A method of manufacturing the article and kits comprising the article are also described.

The present disclosure relates to a nicotine inhaler (100) configured to deliver vaporized nicotine without combustion. The inhaler (100) comprises a housing (105) enclosing a solution chamber containing a nicotine solution (135), a wick (130) configured to transport the solution to a piezoelectric disk (150), and a printed circuit board (PCB) (115) connected to a battery (120). The PCB (115) supplies high-frequency signals to actuate the piezoelectric disk (150), which atomizes the nicotine solution into a fine mist. A power button and recharge port (125) are configured for user activation and battery charging. The vaporized mist is guided through an outlet section (155) to a detachable spout (110) for inhalation. The device enables controlled, smoke-free nicotine delivery using ultrasonic atomization, offering a cleaner alternative to traditional methods.

A synthetic nicotine substitute for use in a variety of delivery systems, particularly in electronic nicotine delivery systems, such as atomizers, electronic cigarettes, combustion, heat-not-burn products, oral or nasal nicotine delivery systems. (S)-6-methylnicotine, also known as (S)-2-methyl-5-(1-methylpyrrolidine-2-yl) pyridine, is a derivative of nicotine, and the 6-site of the pyridine ring of the (S)-6-methylnicotine is substituted by methyl. Preliminary experimental data show that the efficacy of (S)-6-methylnicotine is about 4-5 times (by weight) of nicotine, the (S)-6-methylnicotine can take effect more quickly, and the nicotine desire can be controlled or met more effectively. The carboxylate is also applicable. The enhanced efficacy enables people to alleviate nicotine craving faster and more effectively with a lower dose, and produces a subjective satisfaction to meet the smoking addiction. This enhanced pharmacological efficacy allows for the use of smaller amounts of active ingredients compared to synthetic nicotine formulations, among other potential benefits.

Provided according to one embodiment of the present invention are an aerosol-generating article and an aerosol-generating system including same, the aerosol-generating article comprising a medium part and at least one filter part, wherein the filter part is flavored, and the flavored filter part is located at the distal end (tobacco end) of the aerosol-generating article.

The present invention relates to an oral product for nicotine delivery comprising or consisting of a composition comprising: at least one nicotine salt of a fatty acid, at least one carrier and less than 25% by weight, preferably in an amount of 5 to 15% by weight, more preferably 5 to 10% by weight, of water, based on the total weight of the composition. The invention further relates to a method for preparing an oral product.

FIELD: hygiene; toxicology; preventive medicine.SUBSTANCE: used for quantitative assessment of the total nicotine load in individuals using electronic nicotine delivery systems (ENDS). The average daily volume of liquid consumed, the concentration of nicotine in it, and the length of time of ENDS use in years are determined. The obtained data is processed by calculating the integral nicotine load index (INLI) in conventional units of “vape-years” using an original mathematical formula, taking into account the standard daily dose of nicotine.EFFECT: method ensures the objectification of risk stratification and increases the effectiveness of clinical observation of ENDS users through a quantitative assessment of the accumulated toxic load, taking into account the totality of the period of use and the physical and chemical parameters of the consumed liquid.1 cl, 3 ex